NFO review: ITI Pharma and Healthcare Fund

On October 18, 2021, ITI Mutual Fund rolled out a new fund offer (NFO) that will provide exposure to the pharma and healthcare theme. The newbie, ITI Pharma and Healthcare Fund, will be benchmarked to the NIFTY Healthcare Index and is the sixth pharma and healthcare fund being launched after the outbreak of the COVID-19 pandemic. The scheme will close for subscription on November 01, 2021, and will be managed by Pradeep Gokhale and Rohan Korde. About the strategy The scheme aims to give investors exposure to companies in the healthcare field, such as pharma, hospitals, medical devices and supplies, laboratories and diagnostics, medical insurance, etc. "The covid-19 pandemic has given a new thrust to the Indian pharma sector. ITI Pharma and Healthcare Fund is confident of offering a unique investment experience to its investors by adopting diligent and research-backed investment processes. The fund house follows the investment philosophy of SQL - Margin of Safety, Quality of the business and Low Leverage and offers a superior investment experience to its i